MULTISOURCE (GENERIC) PHARMACEUTICAL …
Working document QAS/14.583/Rev.1 July 2014 Document for comment 1 2 3 MULTISOURCE (GENERIC) PHARMACEUTICAL 4 PRODUCTS: GUIDELINES ON REGISTRATION 5 REQUIREMENTS TO ESTABLISH
Download MULTISOURCE (GENERIC) PHARMACEUTICAL …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD)
npra.moh.gov.mydrug registration guidance document (drgd) drug registration guidance document (drgd) national pharmaceutical regulatory division ministry of health, malaysia
Electronic registration process - European …
www.ema.europa.euElectronic registration process – EudraVigilance registration phases I, II and III EMA/101243/2016 Page 3/8 Step 3: Select transmission mode
European Medicines Agency
www.ema.europa.euEuropean Medicines Agency 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 85 75 Fax (44-20) 75 23 70 40 E-mail: mail@emea.eu.int http://www.emea.eu.int
ICH and EU regulatory framework and the role of …
www.ich.orgAlberto Ganan Jimenez, PhD –Quality of Medicines, European Medicines Agency (EMA) An agency of the European Union ICH and EU regulatory framework and the role of the European Medicines Agency (EMA)
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines eCTD Submission in South Africa . 2.23_Submission_in_eCTD_format_Sept16_v2.1 Page April 2017. 1 of 26. MEDICINES CONTROL COUNCIL
DEVELOPING A CULTURE OF …
www.pugatch-consilium.comDeveloping a Culture of Pharmacovigilance 3 LIST OF ABBREVIATIONS 4 EXECUTIVE SUMMARY 7 INTRODUCTION 11 1 THE IMPORTANCE OF MONITORING THE SAFETY OF MEDICINES 14 1.1 The biopharmaceutical R&D process 14
From access to adherence - World Health …
www.who.intFrom access to adherence: the challenges of antiretroviral treatment Studies from Botswana, Tanzania and Uganda 2006 Anita Hardon University of Amsterdam
The new Clinical Trial Regulation and corresponding …
dgra.deThe new portal and database have to be set up as completely new IT systems by the European Medicines Agency (EMA). These systems will be used to collect data about planned and